Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Updated: Zentalis lays off 40% of staff, whittles down indications for WEE1 inhibitor
4 months ago
People
Judge's ruling clears way for Aurion Biotech's IPO, investor Alcon to appeal
4 months ago
Cell/Gene Tx
Law
Ahead of earnings, Lilly culls mid-stage drug for heart failure and chronic kidney disease
4 months ago
R&D
Pharma
AstraZeneca and Daiichi Sankyo's Enhertu approved in 'ultralow' HER2 patients
4 months ago
Pharma
FDA+
Ozempic label expanded to include reduced risk of worsening kidney disease
4 months ago
Pharma
FDA+
Novo Nordisk asks Third Circuit to expedite IRA case as participation deadline looms
4 months ago
Pharma
Law
One February FDA adcomm meeting is delayed, another canceled
4 months ago
FDA+
Semaglutide, tirzepatide compounder hit with FDA warning letter
4 months ago
FDA+
Manufacturing
What we know — and don’t know — about insurance denial rates
4 months ago
Health Tech
Leap Therapeutics treks toward pivotal study in colorectal cancer, drops gastric cancer
4 months ago
R&D
The RFK question: Trump's HHS nominee splits biopharma before moment of truth
4 months ago
People
FDA+
Akero, 89bio disclose public offerings; BioAge drops Phase 2 obesity drug
4 months ago
News Briefing
Lantheus to buy radiopharma CDMO and diagnostic assets for $250M upfront
4 months ago
Deals
Manufacturing
Atalanta gets $97M boost to take two siRNAs into clinic for rare neuro disorders
4 months ago
Financing
Startups
ITM aims to compete with Novartis after Phase 3 radiopharma win
4 months ago
R&D
Versant's fourth obesity biotech starts with $65M and a GIP antagonist
4 months ago
Financing
Startups
Updated: Cell therapy biotech Affini-T Therapeutics reduces staff
4 months ago
People
Cell/Gene Tx
Sarepta shares two-year DMD study data that could inform European approval decision
4 months ago
R&D
Pharma
Pharmacy middlemen lose bid to toss new Hawaii complaint
4 months ago
Pharma
Law
Obesity startup Found drives weight loss with low-cost generic drugs over GLP-1s, new study shows
4 months ago
Startups
Health Tech
Pfizer inks $60M settlement to close Nurtec anti-kickback suit
4 months ago
Pharma
Law
Sage turns down Biogen's buyout offer and will look at other options
4 months ago
Deals
Pharma
Bristol Myers shares IO combo data in colorectal cancer; Pfizer still waiting on Braftovi regimen survival figures
4 months ago
R&D
Pharma
Trump blog: Federal agencies must give jobs back to fired probationary workers, judge rules
4 months ago
Pharma
FDA+
First page
Previous page
49
50
51
52
53
54
55
Next page
Last page
